Skip to content

PHARDEP

Active Private limited companyfounded 2018active for 8 yearsRue Léon Delhaize 23, 1342 Ottignies-Louvain-la-NeuveKBO/BCE: BE 0695.791.193

Lifetime

7 annual accounts with figures on one time axis
peak of €45,629 in 2019
€29,630▼ 8.8%
peak of €25,104 in 2019
€20,467▲ 4.7%
peak of €94,332 in 2023
€58,738▼ 35.4%
€58,779▲ 71.4%
Board4 names since 2018
2 directors and 1 other
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Dividend €52,600Equity from €90,871 to €58,738Debts from €34,302 to €58,779

Key points

from the 2025 annual accounts

Equity

€58,738 ▼ 35.4%
90,8712024+20,467Profit-52,600Dividend58,7382025

PHARDEP paid out €52,600 in dividends. That is 257% of the 2025 profit.

Turnover

≈ €130,000 estimated

The micro format states no turnover.

Filings

7 annual accounts 1 late
AprilJune31 JulyOctober202020222024

The 2025 accounts came 31 days late. The other six were filed on time.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,977 companies had the same profile as PHARDEP has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,977 companies, not a prediction for PHARDEP. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 08-05-2018
Director, since 01-11-2021
  • 167 sharesdeed of 11-05-2018
  • 19 sharesdeed of 11-05-2018
Board & ownership

Recent changes

(director) and (director) change roles Director discharge: · General meeting of 18-11-2021 · Gazette deed
Incorporation Founding capital of €18,600, 186 shares, €6,200 paid up · Founded by ; · (manager) and (manager) appointed · published on 11-05-2018 · Gazette deed
First establishment Rue Léon Delhaize 23, Ottignies-Louvain-la-Neuve
All 11 events

Comparable companies

same main activity, similar in size and age
Company
PHARDEP Ottignies-Louvain-la-Neuve €117,517 €29,630 50.0% -
SAB Pharma Péruwelz €106,135 €38,513 27.8% -
APEGO Geel €89,749 €36,274 65.9% -
PHARMACIE CAPUCINE Brussels €147,304 €22,550 82.1% -
MEDLINX LINA Schaerbeek €130,245 €42,645 16.9% -
Philexis Kraainem €101,847 €28,245 93.7% -
Van Meirhaeghe Katrien Herzele €84,640 €34,286 12.1% -

These companies have the same main activity as PHARDEP: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €84,600 and €147,000, founded between 2018 and 2021.

Official details

Source: KBO
Status
Active since 08-05-2018Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 1 other
Establishment unit
2.276.125.3881342 Ottignies-Louvain-la-Neuve, since 08-05-2018
Financial year end
31 December
Peppol
Reachable
Company details

Annual accounts 2025

€117,517▼ 6.1%
Filing
Filed on 31-08-2026
Financials

Insights on PHARDEP

PHARDEP files the micro format. That format states no turnover. The gross margin fell from €45,629 in 2019 to €29,630 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARDEP

What is the company number of PHARDEP?
The company number of PHARDEP is 0695.791.193. The VAT number is the same number with BE in front: BE 0695.791.193.
Where is PHARDEP based?
The registered office is at Rue Léon Delhaize 23, 1342 Ottignies-Louvain-la-Neuve.Company details
What does PHARDEP do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARDEP?
PHARDEP is a private limited company (BV).
When was PHARDEP founded?
PHARDEP was founded on 08-05-2018.
Is PHARDEP still active?
Yes, PHARDEP is an active enterprise in the KBO register.
What is the turnover of PHARDEP?
The turnover in financial year 2025 is ≈ €130,000. This figure is estimated from the gross margin of €29,630 and 56 comparable companies (NACE 477). It probably lies between €75,000 and €240,000.Financials
Is PHARDEP profitable?
In financial year 2025, PHARDEP made a profit of €20,467.
Where can I find the annual accounts of PHARDEP?
PHARDEP filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARDEP due?
PHARDEP must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.